GLP-1s may increase long-run healthcare spending

Preventing chronic disease can extend years of baseline healthcare costs while adding the ongoing cost of the drugs themselves

In the long run, decent chance that GLP-1s are going to **increase** healthcare expenditures. Preventing chronic disease means more years of basal healthcare expenses, while patients still ultimately have to die of something. Plus the GLP